Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

The Latest Pharma Jobs, News and Events

pharmiweb.com today | 21 August 2014

GSK receives FDA approval for Arnuity™ Ellipta® (fluticasone furoate) in the USA for the treatment of asthma

GlaxoSmithKline plc announced that the Food and Drug Administration has approved Arnuity™ Ellipta® (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older. Arnuity is not indicated for relief of acute bronchospasm.

The approved doses are Arnuity Ellipta 100mcg and 200mcg. Arnuity Ellipta is administered once daily via the dry powder inhaler called Ellipta, which is also used across a range of other approved respiratory medicines in the GSK portfolio....

show more

Latest Poll

Would you ever take part in a Clinical Trial?

Yes 40% 40%
Possibly 22% 22%
Probably not 22% 22%
Never 15% 15%
Advertising

Content

PharmiWeb.com is a product of PharmiWeb Solutions - a global provider of digital solutions for the pharmaceutical sector.

We increase engagement with healthcare professionals, patients, carers and consumers, through:

Click here to go to learn more about us.

Pharmiweb Solutions